Ken Cacciatore
Stock Analyst at TD Cowen
(0.29)
# 4,016
Out of 4,818 analysts
14
Total ratings
25%
Success rate
-30.5%
Average return
Main Sectors:
Stocks Rated by Ken Cacciatore
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARQT Arcutis Biotherapeutics | Maintains: Outperform | $65 → $50 | $14.45 | +246.02% | 2 | Aug 9, 2023 | |
| BHC Bausch Health Companies | Downgrades: Market Perform | n/a | $5.17 | - | 1 | Jun 16, 2023 | |
| TAK Takeda Pharmaceutical Company | Maintains: Outperform | $30 → $20 | $15.18 | +31.75% | 4 | May 16, 2023 | |
| SCPH scPharmaceuticals | Initiates: Outperform | $25 | $2.60 | +861.54% | 1 | Dec 1, 2022 | |
| BLCO Bausch + Lomb | Initiates: Outperform | $35 | $12.78 | +173.97% | 1 | May 11, 2022 | |
| MOLN Molecular Partners AG | Initiates: Outperform | $50 | $3.89 | +1,185.35% | 1 | Jul 13, 2021 | |
| TARA Protara Therapeutics | Initiates: Outperform | $50 | $4.20 | +1,090.48% | 1 | Oct 19, 2020 | |
| BHVN Biohaven | Initiates: Outperform | $45 | $21.48 | +109.50% | 1 | Apr 17, 2020 | |
| AMRN Amarin Corporation | Initiates: Outperform | $460 | $10.41 | +4,318.83% | 1 | Mar 2, 2020 | |
| OPTN OptiNose | Initiates: Outperform | $375 | $9.18 | +3,984.97% | 1 | Dec 18, 2019 |
Arcutis Biotherapeutics
Aug 9, 2023
Maintains: Outperform
Price Target: $65 → $50
Current: $14.45
Upside: +246.02%
Bausch Health Companies
Jun 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $5.17
Upside: -
Takeda Pharmaceutical Company
May 16, 2023
Maintains: Outperform
Price Target: $30 → $20
Current: $15.18
Upside: +31.75%
scPharmaceuticals
Dec 1, 2022
Initiates: Outperform
Price Target: $25
Current: $2.60
Upside: +861.54%
Bausch + Lomb
May 11, 2022
Initiates: Outperform
Price Target: $35
Current: $12.78
Upside: +173.97%
Molecular Partners AG
Jul 13, 2021
Initiates: Outperform
Price Target: $50
Current: $3.89
Upside: +1,185.35%
Protara Therapeutics
Oct 19, 2020
Initiates: Outperform
Price Target: $50
Current: $4.20
Upside: +1,090.48%
Biohaven
Apr 17, 2020
Initiates: Outperform
Price Target: $45
Current: $21.48
Upside: +109.50%
Amarin Corporation
Mar 2, 2020
Initiates: Outperform
Price Target: $460
Current: $10.41
Upside: +4,318.83%
OptiNose
Dec 18, 2019
Initiates: Outperform
Price Target: $375
Current: $9.18
Upside: +3,984.97%